Skip to main content
. 2016 Jan 6;14(1):e1002344. doi: 10.1371/journal.pbio.1002344

Fig 7. Efficient lysis of CLL patient tumor cells.

Fig 7

Peripheral B cells isolated from the blood of six CLL patients were opsonized with wild-type or mutant, 7D8, RTX or control (IgG1-b12) antibody and tested in CDC assays. The CLL cells of patient 4 were highly refractory to CDC due to their very low CD20 expression.